To gain insight into the time course of mTOR and angiotensin activation in the progression of HF, we defined the effect of rapamycin, ARB and their combination on TAC mice with established remodeling but without HF (compensated hypertrophy, TAC-COMP). This evidence concerns the gene COMP and hydrops fetalis.